ResMed Director Jan De Witte Reports Sale of $101,673 in Common Shares
- ResMed director Jan De Witte sold 429 shares of common stock at $237 per share on Nov. 17, 2026.
- His direct holdings totaled 3,772 shares following the transaction, reported in a Form 4 dated Nov. 18, 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000943819-26-000107), on November 18, 2026, and is solely responsible for the information contained therein.